Unknown

Dataset Information

Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome.


ABSTRACT:

Background

Treatment with thiazolidinediones (TZDs) produces weight gain.

Objective

To test whether a portion control diet could prevent weight gain during treatment with pioglitazone in patients with type 2 diabetes mellitus (T2DM).

Design

This 16-week randomized, open-label, parallel arm study compared three groups: (i) pioglitazone plus the American Diabetes Association diet (Pio + ADA); (ii) pioglitazone plus a portion control weight loss diet (Pio + PC); (iii) metformin plus the American Diabetes Association diet (Met + ADA). All participants received the same advice about calorie reduction, lifestyle change and exercise.

Methods

Fifty-one men and women with T2DM, naive to TZDs, were randomized to a 16-week study. Pioglitazone (Pio) was titrated to a dose

SUBMITTER: Gupta AK 

PROVIDER: S-EPMC2748337 | biostudies-literature | 2009 Apr

REPOSITORIES: biostudies-literature